Hotgen

China
Shuanghejiedao, Sichuan, China

Company profile

Hotgen company profile

Hotgen engages in research, develops, and manufactures medical and public safety inspection products. It is a diagnostic technology platform that develops and expands liquid biopsy early screening technology for cancer and establishes a multi-omics diagnostic technology platform including protein markers, sugar chain exosomes, and DNA methylation. Their technology deploys antibody drugs, live bacteria drugs, exosome drugs, and other biopharmaceutical fields and creates a development strategy for the entire industry chain, from diagnosis to treatment.

Business identity

Contact email
[email protected]
Phone number
400-815-1117
Operating status
Active
Company type
For Profit
Employee range
1,001-5,000 employees
Founded
2005-06-23

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$5M
Last funding
Series B / $3M / 2019-01-11
Last equity funding
Series B / $3M
Investors
3
Lead investors
2
Exited on
2019-09-30

Founders and investors

Lead investors

Fortune Venture CapitalShenZhen GTJA Investment Group

Investors

Fortune Venture CapitalGreenriver InvestmentShenZhen GTJA Investment Group